Key result
In a Chinese population of 102,358 adults, the overall prevalence of cardiometabolic multimorbidity was 11.6%, with increasing age, alcohol consumption, and elevated triglycerides identified as significant risk factors.
Why the study?
Previous studies have primarily examined individual cardiometabolic diseases, leaving limited research on cardiometabolic multimorbidity (CMM) and its predictive risk factors in the Chinese population.
Population
102,358 participants aged 35–75 years from the China-PEACE MPP
Comparison
Demographic variables and modifiable risk factors evaluated for association with CMM
Design
Cross-sectional study
Authors
Loading...
Highlights multimorbidity burden in Chinese adults; hypothesis-generating for targeted prevention pending longitudinal data.
Cross-Sectional (n=102,358)
Yes
In a large Chinese cohort, over 11% of adults aged 35-75 have cardiometabolic multimorbidity, highlighting the need for targeted prevention and management strategies.
Xu et al. (2024) conducted a cross-sectional in Cardiometabolic Multimorbidity (n=102,358). Cardiometabolic risk factors (age, alcohol, triglycerides, medication use) vs. Reference groups without these risk factors was evaluated on Prevalence of Cardiometabolic Multimorbidity (CMM). In a Chinese population of 102,358 adults, the overall prevalence of cardiometabolic multimorbidity was 11.6%, with increasing age, alcohol consumption, and elevated triglycerides identified as significant risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: